Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

被引：0
|
作者：
Jean-François Yale
Taner Damci
Marcel Kaiser
Eddy Karnieli
Kamlesh Khunti
Andreas Liebl
Florian MM Baeres
Anne Louise Svendsen
Stuart A Ross
机构：
[1] Royal Victoria Hospital,McGill Nutrition and Food Science Centre
[2] Istanbul University,Department of Endocrinology, Cerrahpasa Medical School, Diabetes and Metabolism
[3] Practice for Internal Medicine and Diabetology,Endocrinology, Diabetes & Metabolism
[4] Rambam Medical Center and Rappaport Faculty of Medicine,Diabetes Research Centre
[5] University of Leicester,Center for Diabetes and Metabolism
[6] m&i-Fachklinik Bad Heilbrunn,undefined
[7] Global Medical Affairs,undefined
[8] Department of Biostatistics & Epidemiology,undefined
[9] University of Calgary,undefined
[10] the SOLVE Study Group,undefined
来源：
Diabetology & Metabolic Syndrome | / 5卷
关键词：
Type 2 diabetes mellitus; Insulin therapy; Weight; Body mass index; Insulin dose; Hypoglycaemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus
    Enrique Machado-Alba, Jorge
    Enrique Machado-Duque, Manuel
    Andrea Moreno-Gutierrez, Paula
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 107 (03) : 332 - 337
  • [22] Less weight gain and hypoglycaemia with once-daily insulin detemir than with NPH insulin in basal-bolus therapy of overweight type 2 diabetes patients: The PREDICTIVE-BMT trial
    Montanana, C. Fajardo
    Herrero, C. Hernandez
    Fernandez, M. Rivas
    DIABETOLOGIA, 2007, 50 : S404 - S404
  • [23] For type 2 patients requiring basal insulin initiation, insulin detemir offers the flexibility of once-daily dosing in the morning or evening:: 3-month results from PREDICTIVE™
    Gallwitz, Baptist
    Trippe, Bruce
    Zhang, Kezhou
    Lueddeke, Hans-Joachim
    DIABETES, 2007, 56 : A146 - A147
  • [24] Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes
    Vora, J.
    Caputo, S.
    Damci, T.
    Orozco-Beltran, D.
    Pan, C.
    Svendsen, A. L.
    Solje, K. S.
    Khunti, K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (02) : 136 - 143
  • [25] Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)
    Orozco-Beltran, Domingo
    Artota-Menendez, Sara
    ATENCION PRIMARIA, 2016, 48 (02): : 95 - 101
  • [26] Study of Once-Daily Levemir (SOLVE™): Patient quality of life and physician resource utilisation of once-daily insulin detemir in Chinese patients with type 2 diabetes
    Pan, C.
    Lu, J.
    Wang, P.
    Ji, Q.
    Ji, L.
    DIABETOLOGIA, 2012, 55 : S389 - S390
  • [27] Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown, Adrian
    Guess, Nicola
    Dornhorst, Anne
    Taheri, Shahrad
    Frost, Gary
    DIABETES OBESITY & METABOLISM, 2017, 19 (12): : 1655 - 1668
  • [28] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    DIABETOLOGIA, 2011, 54 : S420 - S421
  • [29] Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type 2 diabetes:: subgroup analysis from the PREDICTIVE™ study
    Dornhorst, A.
    Lueddeke, H. -J.
    Sreenan, S.
    Kozlovski, P.
    Hansen, J. B.
    Looij, B. -J.
    Meneghini, L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (04) : 659 - 665
  • [30] Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain
    María Costi
    Tatiana Dilla
    Jesús Reviriego
    Conxa Castell
    Albert Goday
    Acta Diabetologica, 2010, 47 : 169 - 175
12345